Could a potato starch supplement help stem cell transplant recovery?

NCT ID NCT05135351

Recruiting now Disease control Sponsor: University of Nebraska Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 28, 2026 · Updated 3 times

Summary

This study tests whether a prebiotic supplement called resistant starch can improve gut microbiome diversity in people with multiple myeloma or lymphoma after an autologous stem cell transplant. Thirty participants will take either the prebiotic or a placebo for about 10 days before and after their stem cell infusion. The main goal is to see if this approach is feasible and whether it affects gut bacteria diversity at the time of engraftment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Resistant starch (a prebiotic supplement)
What this could lead to: If it works, this could point toward a simple dietary supplement to improve gut health and possibly outcomes after stem cell transplant.
What could go wrong: This is a very small pilot study (30 people) testing feasibility, not effectiveness. The supplement may not change gut diversity or improve health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hodgkins lymphoma lymphoma non-Hodgkin lymphoma plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LYMPHOMA MULTIPLE MYELOMA

Contacts and locations

Locations

Unversity of Nebraska Medical Center
RECRUITING

Omaha, Nebraska, 68198, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.